Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 5, 2011, Pages 1057-1064

  Liu, Chen Hua ^a   Liang, Cheng Chao ^b   Huang, Kai Wen ^a   Liu, Chun Jen ^a   Chen, Shih I ^a   Lin, Jou Wei ^a   Hung, Peir Haur ^c   Tsai, Hung Bin ^d   Lai, Ming Yang ^a   Chen, Pei Jer ^a   Chen, Jun Herng ^a   Chen, Ding Shinn ^a   Kao, Jia Horng ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; GOLD STANDARD; HEMODIALYSIS; HEPATITIS C; HUMAN; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT;

EID: 84984572895     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04320510     Document Type: Article

References (43)

1. Fabrizi F, Poordad FF, Martin P: Hepatitis C infection and the patient with end-stage renal disease. Hepatology 36: 3-10, 2002
2. Berenguer M: Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 48: 1690-1699, 2008
3. Martin P, Fabrizi F: Hepatitis C virus and kidney disease. J Hepatol 49: 613-624, 2008
4. Liu CH, Kao JH: Treatment of hepatitis C virus infection in patients with end-stage renal disease. J Gastroenterol Hepatol 26: 228-239, 2011
5. Liu CH, Liang CC, Liu CJ, Lin JW, Chen SI, Hung PH, Tsai HB, Lai MY, Chen PJ, Chen DS, Kao JH: Pegylated interferon alpha-2a monotherapy for hemodialysis patients with acute hepatitis C. Clin Infect Dis 51: 541-549, 2010
6. Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of antihepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 11: 1896-1902, 2000
7. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G: Metaanalysis: Effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther 20: 1271-1277, 2004
8. Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, Fretz C, Thibault V, Cadranel JF, Bernard B, Opolon P, Coriat P, Bitker MO: Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 29: 257-263, 1999
9. Fabrizi F, Dixit V, Messa P, Martin P: Interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials. J Viral Hepat 15: 79-88, 2008
10. Gordon CE, Uhlig K, Lau J, Schmid CH, Levey AS, Wong JB: Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: A systematic review of the literature and meta-analysis of treatment efficacy and harms. Am J Kidney Dis 51: 263-277, 2008
11. Liu CH, Liang CC, Lin JW, Chen SI, Tsai HB, Chang CS, Hung PH, Kao JH, Liu CJ, Lai MY, Chen JH, Chen PJ, Kao JH, Chen DS: Pegylated interferon alpha-2a versus standard interferon alpha-2a for treatment-naive dialysis patients with chronic hepatitis C: A randomised study. Gut 57: 525-530, 2008
12. Liu CH, Liang CC, Liu CJ, Tsai HB, Hung PH, Hsu SJ, Chen SI, Lin JW, Lai MY, Chen JH, Chen PJ, Chen DS, Kao JH: Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy. Gut 58: 314-316, 2009
13. Caste ́ra L, Pinzani M: Non-invasive assessment of liver fibrosis: Are we ready? Lancet 375: 1419-1420, 2010
14. Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med 344: 495-500, 2001
15. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, American Association for the Study of Liver Diseases: Liver biopsy. Hepatology 49: 1017-1044, 2009
16. Ozdoǧan M, Ozgür O, Boyacioǧiu S, Coçskun M, Kart H, Ozdal S, Telatar H: Percutaneous liver biopsy complications in patients with chronic renal failure. Nephron 74: 442-443, 1996
17. Cotler SJ, Diaz G, Gundlapalli S, Jakate S, Chawla A, Mital D, Jensik S, Jensen DM: Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol 35: 191-195, 2002
18. Pawa S, Ehrinpreis M, Mutchnick M, Janisse J, Dhar R, Siddiqui FA: Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease. Clin Gastroenterol Hepatol 5: 1316-1320, 2007
19. Gangji AS, Sohal AS, Treleaven D, Crowther MA: Bleeding in patients with renal insufficiency: A practical guide to clinical management. Thromb Res 118: 423-428, 2006
20. Kaw D, Malhotra D: Platelet dysfunction and end-stage renal disease. Semin Dial 19: 317-322, 2006
21. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ: Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1: 523-525, 1986
22. Bedossa P, Dargere D, Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38: 1449-1457, 2003
23. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38: 518-526, 2003
24. Liu CH, Lin JW, Tsai FC, Yang PM, Lai MY, Chen JH, Kao JH, Chen DS: Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases. Liver Int 26: 1087-1094, 2006
25. Shaheen AA, Myers RP: Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: A systematic review. Hepatology 46: 912-921, 2007
26. Boyacioǧlu S, GÜr G, Yilmaz U, Korkmaz M, Demirhan B, Bilezikçi B, Ozdemir N: Investigation of possible clinical and laboratory predictors of liver fibrosis in hemodialysis patients infected with hepatitis C virus. Transplant Proc 36: 50-52, 2004
27. Schiavon LL, Schiavon JL, Filho RJ, Sampaio JP, Lanzoni VP, Silva AE, Ferraz ML: Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection. Hepatology 46: 307-314, 2007
28. Liu CH, Liang CC, Liu CJ, Hsu SJ, Lin JW, Chen SI, Hung PH, Tsai HB, Lai MY, Chen PJ, Chen JH, Chen DS, Kao JH: The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C. Kidney Int 78: 103-109, 2010
29. Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM: Ultrasound-based transient elastography for the detection of hepatic fibrosis: Systematic review and meta-analysis. Clin Gastroenterol Hepatol 5: 1214-1220, 2007
30. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E: Performance of transient elastography for the staging of liver fibrosis: A meta-analysis. Gastroenterology 134: 960-974, 2008
31. Castéra L, Forns X, Alberti A: Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 48: 835-847, 2008
32. Castéra L, Vergniol J, Foucher J, le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Lédinghen V: Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128: 343-350, 2005
33. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Le ́dinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M: Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41: 48-54, 2005
34. Castéra L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, Couzigou P, de Lédinghen V: Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations. Hepatology 51: 828-835, 2010
35. Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24: 289-293, 1996
36. Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148: 839-843, 1983
37. Sanyal AJ, American Gastroenterological Association: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123: 1705-1725, 2002
38. Poynard T, Halfon P, Castera L, Munteanu M, Imbert-Bismut F, Ratziu V, Benhamou Y, Bourliére M, de Ledinghen V, FibroPaca Group: Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 53: 1615-1622, 2007
39. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Colombo M: Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 56: 968-973, 2007
40. Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, Stiefel P, Pö schl G, Bü chler MW, Seitz HK, Mueller S: Liver stiffness is directly influenced by central venous pressure. J Hepatol 52: 206-210, 2010
41. Khurana S, Simcox T, Twaddell W, Drachenberg C, Flasar M: Dialysis reduces portal pressure in patients with chronic hepatitis C. Artif Organs 34: 570-579, 2010
42. Mederacke I, Wursthorn K, Kirschner J, Rifai K, Manns MP, Wedemeyer H, Bahr MJ: Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int 29: 1500-1506, 2009
43. Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR: Transient elastography: A new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 14: 360-369, 2007